➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Harvard Business School
Boehringer Ingelheim
Medtronic
AstraZeneca
Dow

Last Updated: September 23, 2021

DrugPatentWatch Database Preview

Investigational Drug Information for Benzimidazole


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Benzimidazole?

Benzimidazole is an investigational drug.

There have been 13 clinical trials for Benzimidazole. The most recent clinical trial was a Phase 1 trial, which was initiated on November 11th 2019.

The most common disease conditions in clinical trials are Helminthiasis, Cysticercosis, and Echinococcosis. The leading clinical trial sponsors are Helse Fonna, Sponsor Name Pending, and National Institute of Allergy and Infectious Diseases (NIAID).

There are nine hundred and fifty-four US patents protecting this investigational drug and twenty-four international patents.

Recent Clinical Trials for Benzimidazole
TitleSponsorPhase
Human Soil Transmitted Helminths (STH) Resistance to Benzimidazole in School Aged Children Living in GabonCentre de Recherche Médicale de LambarénéPhase 4
Albendazole Plus High Dose Ivermectin for Trichuriasis in Pediatric PatientsAlejandro KrolewieckiPhase 2
Validating Egg-based Diagnostics and Molecular Markers for the Spread of Anthelmintic ResistanceSwiss Tropical & Public Health InstituteN/A

See all Benzimidazole clinical trials

Clinical Trial Summary for Benzimidazole

Top disease conditions for Benzimidazole
Top clinical trial sponsors for Benzimidazole

See all Benzimidazole clinical trials

US Patents for Benzimidazole

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Benzimidazole ⤷  Try it Free Antidiabetic tricyclic compounds Merck Sharp & Dohme (Rahway, NJ) ⤷  Try it Free
Benzimidazole ⤷  Try it Free Heterocyclic compounds useful in the treatment of disease Epigen Biosciences, Inc. (San Diego, CA) ⤷  Try it Free
Benzimidazole ⤷  Try it Free Heat shock protein 70 (hsp-70) receptor ligands Duke University (Durham, NC) ⤷  Try it Free
Benzimidazole ⤷  Try it Free Heterocyclic compound Takeda Pharmaceutical Company Limited (Osaka, JP) ⤷  Try it Free
Benzimidazole ⤷  Try it Free Phosphonate compounds for treatment of medical disorders Achillion Pharmaceuticals, Inc. (New Haven, CT) ⤷  Try it Free
Benzimidazole ⤷  Try it Free .beta.-D-2'-deoxy-2'-.alpha.-fluoro-2'-.beta.-C-substituted-2-modified-N.s- up.6-substituted purine nucleotides for HCV treatment Atea Pharmaceuticals, Inc. (Boston, MA) ⤷  Try it Free
Benzimidazole ⤷  Try it Free Materials for organic electroluminescent devices Merck Patent GmbH (DE) ⤷  Try it Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Benzimidazole

Drugname Country Document Number Estimated Expiration Related US Patent
Benzimidazole Australia AU2015263620 2034-05-22 ⤷  Try it Free
Benzimidazole Canada CA2947781 2034-05-22 ⤷  Try it Free
Benzimidazole China CN106458913 2034-05-22 ⤷  Try it Free
Benzimidazole European Patent Office EP3145915 2034-05-22 ⤷  Try it Free
Benzimidazole Japan JP2017516771 2034-05-22 ⤷  Try it Free
Benzimidazole South Korea KR20170005861 2034-05-22 ⤷  Try it Free
Benzimidazole Mexico MX2016015182 2034-05-22 ⤷  Try it Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Colorcon
AstraZeneca
Boehringer Ingelheim
Baxter
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.